SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation of Sunesis Pharmaceuticals, Inc. & Its Board of Directors...
25 July 2015 - 3:21AM
Business Wire
Levi & Korsinsky is investigating the Board of Directors of
Sunesis Pharmaceuticals, Inc. (“SNSS” or the “Company”)
(NASDAQ:SNSS) for possible violations of federal securities laws.
The investigation concerns whether SNSS and certain of its officers
and/or directors have violated Sections 10(b) and 20(a) of the
Securities Exchange Act of 1934. On July 23, 2015, SNSS announced
that the Food and Drug Administration would require more clinical
evidence demonstrating the efficacy of the proposed leukemia
treatment vosaroxin before considering its New Drug Application. To
obtain additional information, go to:
http://zlk.9nl.com/sunesis-pharmaceuticals-snss
or contact Joseph E. Levi, Esq. either via email at
jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877)
363-5972.
Levi & Korsinsky is a national firm with offices in New
York, New Jersey, Connecticut and Washington D.C. The firm’s
attorneys have extensive expertise in prosecuting securities
litigation involving financial fraud, representing investors
throughout the nation in securities and shareholder lawsuits.
Attorney advertising. Prior results do not guarantee similar
outcomes.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20150724005657/en/
Levi & Korsinsky, LLPEduard Korsinsky, Esq.Tel:
212-363-7500Toll Free: 877-363-5972Fax: 212-363-7171www.zlk.com
Sunesis Pharmaceuticals (NASDAQ:SNSS)
Historical Stock Chart
From Sep 2024 to Oct 2024
Sunesis Pharmaceuticals (NASDAQ:SNSS)
Historical Stock Chart
From Oct 2023 to Oct 2024
Real-Time news about Sunesis Pharmaceuticals Inc (NASDAQ): 0 recent articles
More Sunesis Pharmaceuticals, Inc. (MM) News Articles